Andreas Bauer Email & Phone Number

Basel, Switzerland

• Overseeing diligence activities (IN-bound, OUT-bound) for BD&L and M&A across different therapeutic areas
• Providing strategic guidance on concrete opportunities under assessment, and supporting diligence leads in preparation for key governance decisions and required stakeholder management
• Ensuring high-quality of partnering DD process for IM and acting as primary interface with broader DD community across the organization
• Directly managing a group of due diligence directors for in-bound / out-bound diligences
• Accountable for the training needs of the DD group

Basel, Switzerland

• Leading global cross-functional due diligence (DD) teams for robust, balanced, and timely DD evaluations across different development units
• Key partner for BD&L to support Mergers & Acquisitions, In-licensing, and Option and Partnering deals
• Reporting of diligence findings and providing guidance / recommendations to senior management
• Successful execution of deals for Novartis’ key strategic areas
• Supporting the Center of Excellence DD for process development and implementation of a harmonized diligence process across different divisions and functions (process development, tool building, training material.
• Providing mentorship to junior colleagues and best practice and knowledge sharing within broader DD community

Basel, Switzerland

• Leading a cross-functional drug discovery project team focused on hepatology indications
• Design and implementation of Lead-/Target-finding and validation strategies
• Supervision of a research lab with lab heads, post doc and lab associates

Basel; Switzerland

• Supervised cross-functional drug discovery project teams focused on Hepatology and Oncology indications
• Accountable for providing leadership directions for project implementation and to communicate concepts and progress to key stakeholders

Basel; Switzerland

• Led a multi-national and cross-functional drug discovery project team to systematically identify and validate epigenetic regulators for Oncology indications
• Development of project strategy for the initiation of early drug development activities in close dialog with Novartis senior management

Basel; Switzerland

• Established and ran proteomics core facility at Novartis
• Primary project partner for target identification activities at Novartis via Proteomics/ Mass spectrometry
• Supervised a cross-functional team of 10 scientists

Heidelberg; Germany

• Established and ran the Biochemistry core facility with 10+ scientists / associates
• Responsible for the systematic large scale protein complex purification and the design and implementation of custom made biochemical assays depending upon project needs
• Provided leadership for project initiation and guidance on the strategic directions of the company
• Substantial contributions to establish and ran research collaborations with 2 pharmaceutical companies

Freiburg; Germany

Wnt Pathway; beta-catenin biology.